Green Thumb Industries GTBIF Stock Analysis And what the future holds for cannabis stocks

M&A market performance suffered in Q3 2023 – Pharmaceutical Technology

The outlook for M&A Q4 2023 remains relatively subdued. Credit: iQoncept via Shutterstock. The third quarter of 2023 saw a slight fall in deal activity

October 31, 2023

Breakthrough in enzyme communication could pave the way for new drugs

A mechanism that could help scientists harness enzymes for use in drug discovery has been discovered in a research breakthrough at the University of Birmingham.

June 20, 2024

CRISPR-Cas13 emerges as a game changer in RNA-targeted therapies

In recent years, the scientific community has made significant strides in the field of gene editing, particularly through the development of the CRISPR (Clustered Regularly

September 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.